UK Faces Investment Strain as Big Pharma Pulls Back

Nearly £2 billion in planned projects has been paused this year.

16 September 2025 · 23:36 UTC

Britain’s pharmaceutical sector is under pressure as major firms have paused almost £2 billion in investments, raising concerns about the country’s attractiveness as a hub for life sciences amid regulatory uncertainty and global competition.